In silico renal clearance model using classical volsurf approach

Journal of Chemical Information and Modeling

Volumn 46, Issue 3, 2006, Pages 1312-1320

  Doddareddy, Munikumar R ^a   Cho, Yong Seo ^a   Koh, Hun Yeong ^a   Kim, Dong Hyun ^a   Pae, Ae Nim ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; DRUG PRODUCTS; MATHEMATICAL MODELS; NEUROLOGY; PRINCIPAL COMPONENT ANALYSIS; STATISTICAL METHODS; TOPOLOGY; TREES (MATHEMATICS);

BIOAVAILABILITY; CENTRAL NERVOUS SYSTEM (CNS); LOW-CLEARANCE COMPOUNDS; VOLSURF APPROACH;

CHEMICAL COMPOUNDS;

ARTICLE; BIOLOGICAL MODEL; HUMAN; KIDNEY; PHYSIOLOGY; REGRESSION ANALYSIS;

HUMANS; KIDNEY; LEAST-SQUARES ANALYSIS; MODELS, BIOLOGICAL;

EID: 33745398350     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci0503309     Document Type: Article

References (30)

1. Norris, D. A.; Leesman, G. D.; Sinko, P. J.: Grass, G. M. Development of predictive pharmacokinetic simulation models for drug discovery. J. Controlled Release 2000, 65, 55.
2. Grass, G. M.; Sinko, P. J. Effect of diverse datasets on the predictive capability of ADME models in drug discovery. Drug Discovery Today 2001, 6, S54.
3. Ekins, S.; Waller, C. L.; Swaan, P. W.; Cruciani, G.: Wrighton, S. A.; Wikel, J. H. Progress in predicting human ADME parameters in silico. J. Pharmacol. Toxicol. Meth. 2000, 44, 251.
4. Ghafourian, T.; Fooladi, S. The effect of structural QSAR parameters on skin penetration. Int. J. Pharm. 2001, 217, 1.
5. Feher, M.; Sourial, E.; Schmidt, J. M. A simple model for the prediction of blood-brain partitioning. Int. J. Pharm. 2000, 201, 239.
6. Martens, H.; Naes, T. Multivariate Calibration; Wiley: Chichester, U.K., 1998.
7. Wold, S.; Esbensen, K.; Geladi, P. Principal component analysis. Chemom. Intell. Lab. Syst. 1987, 2, 37.
8. Dunn, W. J.; Wold, S. Pattern Recognition Techniques in Drug Design. In Comprehensive Medicinal Chemistry; Hansch, C., Sammes, P. G., Taylor, J. B., Eds.; Pergamon Press: Oxford, U. K., 1990; Vol. 4, pp 691-71.
9. Turner, J. V.; Maddalena, D. J.; Cutler, D. J.; Agantonovic-Kustrin, S. Multiple pharmacokinetic parameter prediction for a series of cephalosporins. J. Pharm. Sci. 2003, 92, 518.
10. Yoshida, F.; Topliss, J. G. QSAR model for drug human oral bioavailability. J. Med. Chem. 2000, 43, 2575.
11. Andrews, C. W.; Bennett, L.; Yu, L. Y. Predicting human bioavailability of a compound: development of a novel quantitative structurebioavailability relationship. Pharm. Res. 2000, 17, 639.
12. Gaviraghi, G.; Barnaby, R. J.; Pellegatti, M. Phamacokinetic challenges in lead optimization. In Pharmacokinetic Optimization in drug Research; Testa, B., Van de Waterbeemd, H., Folkers, G., Guy, R., Eds.; Wiley-VCH: Basel, Switzerland, 2001; pp 1-14.
13. Cruciani, G.; Pastor, M.; Guba, W. VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. Eur. J. Pharm. Sci. 2000, 11 (2), S29.
14. Cruciani, G.; Crivori, P.; Carrupt, P. A.; Testa, B. Molecular fields in quantitative structure-permeation relationships: the VolSurf approach. THEOCHEM 2000, 503, 17.
15. Kier, L. B.; Hall, L. H. Molecular Connectivity in Structure-Activity Analysis; Research Studies Press Ltd/Wiley: Letchworth, Hertfordshire, England, 1986.
16. ( 16) Wold, S. Pattern recognition by means of disjoint principal component models. In Pattern recognition; 1976; Vol. 8, p 127.
17. Breiman, L.; Friedman, J. H.; Olshen, R. A.; Stone, C. J. In Classification and Regression Trees; Wadsworth International Group: Belmont, CA, 1984.
18. Crivori, P.; Cruciani, G.; Carrupt, P.; Testa, B. Predicting blood-brain permeation from three-dimensional molecular structure. J. Med. Chem. 2000, 43, 2204.
19. Kier, L. B.; Hall, L. H. Molecular Connectivity in Chemistry and Drug Research; Academic Press: New York, 1976.
20. Hardman, J. G.; Goddman, A. G.; Limbard, L. E. Goddman and Gilman's The Pharmacological Basis of Therapeutics; McGraw-Hill: New York, 1996; pp 1710-1792.
21. XConcord, version 5.1.2; Optive Research, Inc.: Austin, TX, 1986-2003.
22. Clark, M.; Cramer, R. D., Ill; Van Opdenbosch, N. The Tripos Force Field. J. Comput. Chem. 1989, 10, 982.
23. SYBYL, version 7.0; Tripos Inc.: St. Louis, MO, 63144.
24. Volsurf, version 4.1; Molecular Discovery Ltd.: Middlesex, U. K., 2000-2004.
25. Cruciani, G.; Clementi, S. GOLPE: Philosophy and Applications in 3D-QSAR. In Advanced Computer-Assisted Techniques in Drug Discovery; van de Waterbeemd, H., Ed.; VCH: Weinheim, Germany, 1994; pp 61-88.
26. Cruciani, G.; Clementi, S.; Baroni, M.; Pastor, M. Recent Development in 3D-QSAR Methodologies. In Rational Molecular Design in Drug Research; Alfred Benzon Symposium 42; Liljefors, T., Jorgensen, F. S., Krogsgaard-Larsen, P., Eds.; Munskgaard: Copenhagen, Denmark, 1998; pp 87-97.
27. Wold, S.; Albano, C.; Dunn, W. J., Ill; Edlund, U.; Esbensen, K.; Geladi, P.; Helberg, S.; Johansson, E.; Lindberg, W.; Sjostrom, M. Multivariate Data Analysis in Chemistry. In Chemometrics Mathematics and Statistics in Chemistry; Kowalsky, B. R., Ed.; Dordrecht: Holland, 1983; pp 17-96.
28. Cerius2, version 4.10; Accelrys Inc.: San Diego, CA, 2005.
29. Gres, M.; Julian, B.; Bourrie, M.; Meunier, V.; Riques, C.; Berger, M.; Boulenc, X.; Berger, Y.; Fabre, G. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 Cells, A human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm. Res. 1998, 15, 726.
30. Kansy, M.; Senner, F.; Gubemator, K. Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes. J. Med. Chem. 1998, 41, 1007.